Dr Martens /£DOCS
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Dr Martens
Dr. Martens, also known as Docs or DMs, is a United Kingdom-based company renowned for its iconic range of footwear, alongside a variety of clothing and accessories. The company, headquartered in Wollaston, Northamptonshire, operates primarily in the footwear manufacturing sector. Established in 1947, Dr. Martens has grown to become a symbol of self-expression and counterculture, distributing its products worldwide under the Dr. Martens brand.
Ticker
£DOCS
Sector
Primary listing
LSE
Industry
Textiles, Apparel and Luxury Goods
Headquarters
Employees
2,348
ISIN
GB00BL6NGV24
Website
Dr Martens Metrics
BasicAdvanced
£761M
167.66
£0.00
0.15
£0.02
2.35%
Price and volume
Market cap
£761M
Beta
0.15
52-week high
£0.83
52-week low
£0.43
Average daily volume
1.6M
Dividend rate
£0.02
Financial strength
Current ratio
2.591
Quick ratio
1.368
Long term debt to equity
97.107
Total debt to equity
110.289
Dividend payout ratio (TTM)
211.11%
Interest coverage (TTM)
2.01%
Profitability
EBITDA (TTM)
75.7
Gross margin (TTM)
64.97%
Net profit margin (TTM)
0.57%
Operating margin (TTM)
7.71%
Effective tax rate (TTM)
48.86%
Revenue per employee (TTM)
£340,000
Management effectiveness
Return on assets (TTM)
4.12%
Return on equity (TTM)
1.23%
Valuation
Price to earnings (TTM)
167.665
Price to revenue (TTM)
0.958
Price to book
2.07
Price to tangible book (TTM)
8.23
Price to free cash flow (TTM)
4.248
Free cash flow yield (TTM)
23.54%
Free cash flow per share (TTM)
18.46%
Dividend yield (TTM)
2.35%
Growth
Revenue change (TTM)
-10.20%
Earnings per share change (TTM)
-93.32%
3-year revenue growth (CAGR)
-4.64%
10-year revenue growth (CAGR)
12.84%
3-year earnings per share growth (CAGR)
-70.44%
10-year earnings per share growth (CAGR)
36.65%
3-year dividend per share growth (CAGR)
-22.60%
What the Analysts think about Dr Martens
Analyst ratings (Buy, Hold, Sell) for Dr Martens stock.
Bulls say / Bears say
Dr. Martens plans to reduce discounting in key markets, including the U.S., aiming for a return to profit growth in the current financial year. (reuters.com)
The company achieved a significant reduction in inventory by £67 million, surpassing their initial target, and decreased net debt by £95 million, strengthening its balance sheet. (tipranks.com)
Dr. Martens' Americas Direct-to-Consumer segment returned to growth in the second half of FY '25, indicating positive market trends. (tipranks.com)
Dr. Martens reported a 41.7% decrease in profit before tax, primarily due to weaker consumer demand in the U.S. market. (retail-insight-network.com)
The company faced operational challenges, including a poorly implemented transition to a Los Angeles distribution center, negatively impacting U.S. sales. (retaildive.com)
Dr. Martens' wholesale revenues declined by 46%, driven by weak performance in the U.S., indicating potential ongoing challenges in that market. (theguardian.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.
Dr Martens Financial Performance
Revenues and expenses
Dr Martens Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
Aug28
Dr Martens
Dividend·Ex-dividend
Oct8
Dr Martens
Dividend·Payment
£0.017Per share
FAQs
What’s the current market cap for Dr Martens stock?
Dr Martens (DOCS) has a market cap of £761M as of July 18, 2025.
What is the P/E ratio for Dr Martens stock?
The price to earnings (P/E) ratio for Dr Martens (DOCS) stock is 167.66 as of July 18, 2025.
Does Dr Martens stock pay dividends?
Yes, the Dr Martens (DOCS) stock pays dividends to shareholders. As of July 18, 2025, the dividend rate is £0.0184 and the yield is 2.35%. Dr Martens has a payout ratio of 211.11% on a trailing twelve-month basis.
When is the next Dr Martens dividend payment date?
The next Dr Martens (DOCS) dividend payment is scheduled for October 08, 2025.
What is the beta indicator for Dr Martens ?
Dr Martens (DOCS) has a beta rating of 0.15. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.